Creso pharma in partnership with LGC launching beverageshttps://twitter.com/CresoPharma/status/1011054850329665536?s=19
1
ASX Announcement
25 June 2018
Launch of Innovative Infused Terpene Blended Craft Beers and Adult Drinks
Highlights:
• CLV Frontier Brands Pty Ltd, a JV of Creso Pharma, LGC Capital and the Baltic
Beer Company launches beverage business unit.
• Estonian brewing facility is complete and currently finalizing the
development of a range of CLV beers and adult soft drinks.
• Bottling of the first two beers is expected by mid-July 2018.
• Adult soft drinks are now in the final stage of development.
• Brand websites preparing to go live with social media campaigns ready for
launch in the coming weeks.
• UK portfolio launch is set for September 2018.
Creso Pharma Limited (ASX:CPH, the “Company” or “Creso”) is pleased to advise that CLV Frontier
Brands Pty Ltd (CLV), a Joint Venture between Creso Pharma, LGC Capital (TSXV:LG) and UK based
Baltic Beer Company Ltd is progressing well, with a number of products ready for commercial launch.
Figure 1: CLV’s R&D brewing facility in Tallinn, Estonia
2
Facilities
State-of-the-art R&D brewery facility in Tallinn, Estonia is now complete and is being fully utilised to
research and develop a range of CLV beers and adult soft drinks. Once market-ready, CLV has
agreements in place with brewing and bottling partners to produce the products/beverages.
Beers
The first two beers soon to be released under the new CLV umbrella beer brand OLD BOY MARY JANE
(OBMJ) are fermenting at the facilities of CLV’s brewing partner. These 2 new beers OBMJ Ghost Bog
Hazy IPA and OBMJ Improper Klsch will be packed and ready for shipments during July with
updates on a firm release date expected shortly.
Figure 2: Labels of the two beer ranges to be launched by CLV
OBMJ Ghost Bog Hazy IPA and OBMJ Improper Klsch will contain unique terpene blends, which carry
the flavour and aroma of cannabis, but are not derived from cannabis and have no THC, CBD nor any
other cannabinoids.
The initial focus for these bottled beers is the UK followed by other European and global markets.
Discussions have already started and are advanced in Canada regarding licensed production in cans.
Discussions are also in progress with distributors in Australia, Israel and a number of other key
markets.
Marketing and social media campaigns are being finalized and will incorporate the branding tag line:
‘Beer with substance’ and the landing page for OBMJ www.obmj.beer is due to go live shortly.
3
Soft drinks
The first adult soft drink range will comprise a selection of juice-based drinks containing various
terpene blends. Recipe testing production is due to start by the end of June 2018. These products will
fall under the newly created brand, GYPSY. The upcoming launch of the brand website
www.gypsydrinks.com will be the starting point for a social media campaign which will promote
Gypsy Sparkling Water, Gypsy Adult Soft Drink and Gypsy Tonic Water which are all due to be
launched shortly. Official branding remains confidential at this stage, but will be released just prior to
commercial launch.
Director of Baltic Beer Company, Paul Baxendale, is planning the sales and operational strategies for
Old Boy Mary Jane beers and the Gypsy drinks in the UK. The portfolio launch kicks off in September
2018 at the Boutique Bar Show in London with a wider European launch planned for October 2018 at
the Anuga Exhibition in Cologne Germany.
CLV will have wide-spread commercialisation reach across numerous continents and intends to make
full use of the networks of all three companies for marketing and distribution, strictly in compliance
with all local and international laws.
Figure 3: CLV’s testing of the Gypsy range of adult soft drinks
Intellectual property
Trademark applications for Old Boy Mary Jane beers and Gypsy have been submitted in numerous
markets following intensive research, and applications are progressing well.
Creso’s Co-founder and CEO, Dr Miri Halperin Wernli, said: “We are very excited about the
imminent launch of these unique creative products infused with natural organic terpene blends that
bring unusual and exciting flavours and aromas. We see a lot of potential value in this growing market
and anticipate a successful initial portfolio launch in Europe. Through the vast geographic reach of the
three parties in this venture we can look forward to opportunities for this innovative new range of
drinks to be produced and sold globally.”
4
Paul Baxendale, Baltic Beer Company’s Managing Director and Sales and Marketing Director,
stated: “This is an exciting new direction for the drinks industry. Terpenes can provide whole new
layers of natural flavours that you cannot get from traditional ingredients alone. The growth of craft
beers shows that consumers are not afraid to try something different and we aim to offer an
intriguing dimension to both beers and non-alcoholic drinks.”
John McMullen, CEO LGC Capital, Ltd., stated; “After a successful product testing meeting at CLV’s
offices in Tallinn, Estonia, I believe this is another great leap forward for LGC Capital and our partners
Creso and the Baltic Beer Company. The global beverage market has been expanding rapidly into the
craft beverage lines. With highly individualized and independent young adults demanding a high-end
selection of beverages to choose from, CLV caters to this growing market and provides a connection
with flavours and experiences that the global consumer can fully enjoy. “
---END---
About Creso Pharma Ltd
www.cresopharma.com
Creso Pharma brings the best of cannabis to better the lives of people and animals. It brings
pharmaceutical expertise and methodological rigor to the cannabis world and strives for the highest
quality in its products. It develops cannabis and hemp derived therapeutic, nutraceutical, and life style
products with wide patient and consumer reach for human and animal health. Creso uses GMP
development and manufacturing standards for its products as a reference of quality excellence with
initial product registrations in Switzerland. It has worldwide rights for a number of unique and
proprietary innovative delivery technologies which enhance the bioavailability and absorption of
cannabinoids.
About LGC Capital Ltd
www.lgc-capital.com
LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange
(TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions
that provide shareholders with exposure to a diverse range of businesses, products and services with
an emphasis on significant investments in global medical cannabis sector.
About Baltic Beer Company Ltd
www.virubeer.com
A UK-based company that created and markets an iconic Estonian beer brand called Viru Premium
Estonian Beer. Viru beer is currently sold in numerous markets around the world including Australia,
China, UK, Italy and Mexico to name a few and has won multiple awards including gold medals at
Monde Selection, Brussels and the World Beer Championships Chicago.
Corporate Queries
EverBlu Capital
P: +61 2 8249 0000
E: info@everblucapital.com